GSK’s formulation of the drug, Zantac, was recalled in the USA last month after the FDA found “unacceptable” levels of carcinogen in the medicine. More: More prescription ranitidine recalled from shelves Source: News
read moreThe four-hour workshop will educate students aged seven to 13 on heart health. More: Bayer announces ‘Heart Mechanics’ workshop for schools Source: News
read moreThe money will go towards the development of the new “Spark Building”, which will provide interim lab and office accommodation whilst more permanent accommodation is developed nearby. More: Stevenage Bioscience bags £1.2m cash injection Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals